Current Treatment Options in Allergy Impact Factor 2026: 1.41, Quartile

Publishing your own paper?

Get it ready for the right journal with a PhD expert in your field.

Manuscript Auditing

A PhD reviewer in your exact area sends a structured, section-by-section critical review.

AI plagiarism and similarity report included
Secure, confidential upload

Audit duration: within 1 weekCheck price →

If the journal needs LaTeX

LaTeX Template Conversion

We convert your manuscript into the LaTeX template your target journal requires.

Check price →

If your paper was out of scope

Journal Selection & Submission

Up to 5 journals matched to your indexing (SCIE / Scopus) and quartile
Submission handled, with weekly updates

With LaTeX conversion: within 2 Working DaysCheck price →

What is ScholarsColab?

ScholarsColab is a freelancing platform built for researchers, with a pool of research doctorates registered to mentor them. Hire one in your research area and cut your research timeline from 2 years to 2 months.

Know more →

At a glanceCurrent Treatment Options in Allergy is listed in ESCI, Scopus, JCR 2024. Published by Springer Science+Business Media, it has 418 published works, cited 2,897 times (h-index 28). Its impact factor* of 1.41 ranks it 25 of 41 in Allergy. Its papers take a median of 67 days from submission to acceptance. 33% of its recent research articles name a funder, most often University of Antioquia. Papers by ScholarsColab mentors and the researchers we track appear here as soon as they publish in it. Data updated 22 October 2026.

Official website Guide for authors and submission Check my manuscript first

Impact factor*1.41Rank 25 of 41 in Allergy IndexingESCIScopusJCR 2024Confirm on the official lists before you submit Review time67 daysMedian from submission to acceptance

RetractionsNoneNone on record under this name

LaTeX template available

Springernature provides LaTeX templates for many of its journals. Check this journal’s author guidelines, and we can convert your manuscript into its template.

LaTeX Template Conversion →

01Impact factor

Impact factor of Current Treatment Options in Allergy (2026)

Impact factor (2-year)1.41calculated by ScholarsColab

Rank in category#25of 41 by citedness

APC (listed)US$3,890article charge

h-index28

Papers published418cited 2,897 times

The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers Current Treatment Options in Allergy published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, calculated by ScholarsColab. The journal is listed in JCR 2024, so it also has an official Journal Impact Factor published by Clarivate, which can differ because it counts citations from Web of Science journals only.

Rank in its subject categories

Allergyrank 25 of 41 journals

Ranks here compare journals of the same Web of Science category in our data by 2-year citedness; they are not the official JCR rank.

Quartile of Current Treatment Options in Allergy

A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Current Treatment Options in Allergy is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.

Citations and papers per year

Citations per year

Papers per year

Article processing charge listed at about US$3,890.

Please check the final impact factor. The impact factor and APC on this page are calculated by ScholarsColab (updated 17 October 2026) and can differ from the official values. Confirm the current impact factor and charges on the journal’s website or in Clarivate’s Journal Citation Reports before you submit.

Is your paper a fit for Current Treatment Options in Allergy?

Most desk rejections come from a scope mismatch. Compare your title and abstract with what this journal really publishes. Free, no sign-up, about 2 minutes.

Check my paper for this journal Or find journals that fit my paper

02Review time

Review time of Current Treatment Options in Allergy

Submission to acceptance67 daysmedian

Acceptance to online27 daysmedian

Papers counted28Sep 2025 to Sep 2026

How long papers in this journal took to be accepted

Fastest 10% accepted within 14 daysMiddle half of the papers: 28–90 daysMedian: 67 daysSlowest 10% took over 140 days

Each paper took a different time. The green box holds the middle half of the papers and the dark line is the median; the whiskers reach the fastest 10% and the slowest 10%. Plan with the whole spread, not only the median.

Full analysis: your chances within 3 or 6 months, dates and faster journals →

Half of the research articles Current Treatment Options in Allergy published between Sep 2025 and Sep 2026 were accepted within 67 days of submission, and the middle half took between 28 and 90 days. This time includes peer review and any revision rounds. Papers that were rejected are not counted, because only published papers carry these dates.

In Allergy, Current Treatment Options in Allergy ranks 3 of 12 journals by review time (1 = fastest). See the fastest-review journals in Allergy →

Want a journal with a shorter review time for your manuscript? Journal Selection & Submission shortlists matching journals and handles the submission.

Source, method and date. For each of the 28 research articles published from Sep 2025 to Sep 2026 that carry both dates, ScholarsColab counted the days from received to accepted, then took the median and the middle 50% of those values; articles with impossible dates were left out. Updated: 29 October 2026, refreshed about every 3 months. Review times of individual papers vary with the field, the editor, the reviewers and the number of revisions, and the journal may count from a different date. ScholarsColab is not affiliated with this journal; check the journal’s website for its own figures.

Need a faster review? Current Treatment Options in Allergy takes a median of 67 days; the fastest journals in Allergy take 42.

Current Allergy and Asthma Reports 42 days
Clinical Reviews in Allergy & Immunology 68 days
Asia Pacific Allergy 69 days

All fastest journals in this field

APC waivers and discounts for Current Treatment Options in Allergy APC about US$3,890

Springer Nature: 100% waiver for low-income countries and 50% for lower-middle income countries (World Bank list with a GDP limit), on request at submission. Authors in 25 countries get a full waiver.

Check the APC for my country

03Funders

Who funds research published in Current Treatment Options in Allergy

Articles naming a funder33%of 51 recent articles

Funders named most often

University of Antioquia3

National Natural Science Foundation of China3

Charité - Universitätsmedizin Berlin2

Allergy Therapeutics1

CES University1

A high share of funded papers usually means the journal is a common choice for grant-supported work in its field. If your funder pays article processing charges, or your country qualifies for a waiver, check what applies to your author team with the free APC waiver checker.

Based on up to 200 research articles this journal published in the last 24 months. Not every article lists its funders, so the share can be lower than the real one. Updated: 29 October 2026.

04Indexing

Indexing of Current Treatment Options in Allergy

List	Status
Science Citation Index Expanded (SCIE)	Not listed
Social Sciences Citation Index (SSCI)	Not listed
Arts & Humanities Citation Index (AHCI)	Not listed
Emerging Sources Citation Index (ESCI)	✓ Listed
Scopus	✓ Listed
Journal Citation Reports 2024	✓ Listed

ISSN: 2196-3053
Publisher: Springernature
Country: United States
Language: English
Scopus source type: Journal
Web of Science categories: Allergy

From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor on this page is calculated by ScholarsColab (see how the impact factor works).

Verify the indexing yourself

Each link opens the official record for this journal, searched by its ISSN where we have one.

05How to submit

How to submit to Current Treatment Options in Allergy

Read the guide for authors. It sets the article types, word limit, reference style and file format that Current Treatment Options in Allergy accepts. Open the official guide for authors and submit from the same page.
Use the journal's template. Springernature offers Word and LaTeX templates for many of its journals. If your manuscript is in Word and the journal wants LaTeX, our LaTeX Template Conversion moves it into the template.
Check the fit. Read the aims and scope and a few recent issues; papers outside the scope are the most common reason for a desk rejection. The Journal Finder shows journals that published the closest work.
Check the fee. Current Treatment Options in Allergy is not a fully open access journal, so authors usually pay nothing unless they choose open access for their article or the journal charges page or colour fees. The guide for authors states the current charges.
Check your manuscript before you submit. The free Submission Readiness Check asks the seven questions our reviewers ask in every audit and takes about 2 minutes.

06Reviewer comments

Reviewer comments and rejection reasons for Current Treatment Options in Allergy

No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.

Across the reviewer comments researchers have shared with us, the points raised most often are figures, tables and equations (21%), literature and references (12%) and novelty and contribution (10%). Before you submit to Current Treatment Options in Allergy, a Manuscript Audit by a PhD reviewer in your area checks your paper against exactly these points.

Audit my paper before I submit →

Worried about the English? Manuscript editing by editors in your subject: see the price →

Not sure yet? Check if your paper is ready for this journal: free, no AI, under 5 seconds

07Same subject

Allergy journals with a similar impact factor*

The journals next to Current Treatment Options in Allergy when the 39 journals of Allergy in our data are ranked by impact factor*:

Rank	Journal	Impact factor*	Indexing	Open access
21	Immunology and Allergy Clinics of North America	1.80	SCIE	Subscription
22	Allergologia et Immunopathologia	1.74	SCIE	Some open access
23	Pediatric Allergy Immunology and Pulmonology	1.51	SCIE	Subscription
24	Advances in Dermatology and Allergology	1.48	SCIE	Some open access
26	Asian Pacific Journal of Allergy and Immunology	1.39	SCIE	Some open access
27	Journal of Investigational Allergology and Clinical Immunology	1.31	SCIE	Some open access
28	Annals of Allergy Asthma & Immunology	1.23	SCIE	Subscription
29	European Annals of Allergy and Clinical Immunology	1.23	ESCI	Subscription

*Impact factor calculated by ScholarsColab (2-year citedness), not the official Clarivate value.

FreeNo AI

Is Current Treatment Options in Allergy right for your paper? Find the right journal

Paste your title, keywords or abstract. See the journals that published the closest papers, with indexing, impact factor, review time and APC.

Try:

Publishing open access? Your author team may not have to pay the APC. Free APC waiver check for your country→

How it works

No AI or language model is used. Your words are matched against the titles of 157,115 real published journal papers, by our mentors and by other researchers (shown without names); journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; the impact factor is calculated by ScholarsColab, not the official Clarivate value, and no quartile is shown until the official JCR or SJR quartile can be; review time is the median days from submission to acceptance (not every publisher publishes these dates). Always check a journal’s scope and current indexing before submitting.

Want a PhD expert to shortlist and handle the submission? Journal Selection & Submission matches your manuscript to up to 5 suitable journals by indexing and quartile. Check price →

08Questions

Frequently asked questions

How long is the review time of Current Treatment Options in Allergy?

Based on 28 research articles Current Treatment Options in Allergy published from Sep 2025 to Sep 2026, the median time from submission to acceptance was 67 days, and half of them were accepted between 28 and 90 days. After acceptance, papers appeared online after a median of 27 days. Data updated October 2026. Individual papers can take longer, especially with major revisions.

What is the impact factor of Current Treatment Options in Allergy?

Based on ScholarsColab citation data (October 2026), the 2-year impact factor of Current Treatment Options in Allergy is 1.41: papers it published in the two previous years were cited 1.41 times on average in a year. The journal is listed in JCR 2024, so Clarivate also publishes an official Journal Impact Factor, which can differ.

What is the h-index of Current Treatment Options in Allergy?

The h-index of Current Treatment Options in Allergy is 28 (October 2026): 28 of its papers have each been cited at least 28 times. Its i10-index is 74.

What is the APC of Current Treatment Options in Allergy?

The listed article processing charge (APC) is about US$3,890 for Current Treatment Options in Allergy (data from October 2026). APCs change and can differ by article type, country or discounts, so confirm the current charge on the journal’s website before submitting.

What is the quartile of Current Treatment Options in Allergy?

Is Current Treatment Options in Allergy indexed in Scopus?

Yes. Current Treatment Options in Allergy appears in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.

Is Current Treatment Options in Allergy an SCIE journal?

Current Treatment Options in Allergy is listed in ESCI of the Web of Science Core Collection, but not in SCIE, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.

Is Current Treatment Options in Allergy in Journal Citation Reports (JCR)?

Yes. Current Treatment Options in Allergy is listed in JCR 2024, so it has a Journal Impact Factor. For the current impact factor and quartile, check Journal Citation Reports.

Does Current Treatment Options in Allergy offer an APC waiver?

Current Treatment Options in Allergy follows the policy of Springer Nature: 100% waiver for low-income countries and 50% for lower-middle income countries (World Bank list with a GDP limit), on request at submission. Only the corresponding author's affiliation counts. Co-authors from other countries do not change the waiver. Rules verified 27 October 2026; confirm on the publisher's page.

Who funds research published in Current Treatment Options in Allergy?

33% of 51 recent research articles in Current Treatment Options in Allergy name a funder; the funders named most often are University of Antioquia, National Natural Science Foundation of China, Charité - Universitätsmedizin Berlin.